Group comparisons regarding IL-17A and IL-23 yielded different results: the values for PSO–MS group were higher for both interleukins, but IL-17A presented statistically significantly differences compared to the PSO group (p = 0.009), while IL-23 has similar values for both groups. The gene discussed is IL17A; the disease is myeloid sarcoma.